Securities Claims Against Drug Maker, Others Dismissed With Prejudice

Mealey's (August 6, 2018, 2:14 PM EDT) -- PHILADELPHIA — A federal judge in Pennsylvania on Aug. 2 dismissed a securities class action lawsuit with prejudice, ruling that lead plaintiffs have failed to plead the necessary elements of scienter in claiming that a drug company and certain of its executive officers misled investors about the company’s pain management drug, as well as its chances of receiving “oral-abuse deterrent labeling” (In re Egalet Corp. Securities Litigation, No. 17-390, E.D. Pa., 2018 U.S. Dist. LEXIS 130009)....